Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bandelow

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2002
Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorderA Broocks, B Bandelow, K Koch, et al.
Der Nervenarzt|September 1, 1995
[Chronification of sleep disorders. Results of a representative survey in West Germany]S Simen, G Hajak, G Schlaf, et al.
Pharmacopsychiatry|September 1, 1996
Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomniaG Hajak, A Rodenbeck, L Adler, et al.
Pharmacopsychiatry|July 1, 1997
Urinary excretion of cortisol, norepinephrine, testosterone, and melatonin in panic disorderB Bandelow, G Sengos, D Wedekind, et al.
Psychiatry Research|September 7, 2000
Diurnal variation of cortisol in panic disorderB Bandelow, D Wedekind, V Sandvoss, et al.
Neuropsychobiology|January 1, 1997
Exercise avoidance and impaired endurance capacity in patients with panic disorderA Broocks, T F Meyer, B Bandelow, et al.
Der Nervenarzt|May 5, 1998
[The social status of schizophrenic patients]P Müller, W Gaebel, B Bandelow, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 27, 2018
Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI studyA Uhlmann, B Bandelow, D J Stein, et al.
The American Journal of Psychiatry|May 20, 1998
Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorderA Broocks, B Bandelow, G Pekrun, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1992
Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of GermanyB Bandelow, P Müller, U Frick, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2002
Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorderA Broocks, B Bandelow, K Koch, et al.
Der Nervenarzt|September 1, 1995
[Chronification of sleep disorders. Results of a representative survey in West Germany]S Simen, G Hajak, G Schlaf, et al.
Pharmacopsychiatry|September 1, 1996
Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomniaG Hajak, A Rodenbeck, L Adler, et al.
Pharmacopsychiatry|July 1, 1997
Urinary excretion of cortisol, norepinephrine, testosterone, and melatonin in panic disorderB Bandelow, G Sengos, D Wedekind, et al.
Psychiatry Research|September 7, 2000
Diurnal variation of cortisol in panic disorderB Bandelow, D Wedekind, V Sandvoss, et al.
Neuropsychobiology|January 1, 1997
Exercise avoidance and impaired endurance capacity in patients with panic disorderA Broocks, T F Meyer, B Bandelow, et al.
Der Nervenarzt|May 5, 1998
[The social status of schizophrenic patients]P Müller, W Gaebel, B Bandelow, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 27, 2018
Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI studyA Uhlmann, B Bandelow, D J Stein, et al.
The American Journal of Psychiatry|May 20, 1998
Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorderA Broocks, B Bandelow, G Pekrun, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1992
Depressive syndromes in schizophrenic patients under neuroleptic therapy. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich, Federal Republic of GermanyB Bandelow, P Müller, U Frick, et al.
Pageof 8